Clinical research
Puerta de Hierro University Hospital
·Majadahonda, Madrid ·

The group has worked on initiatives to promote hospital care quality, clinical trials with drugs (I-III), prehabilitation in patients with localized disease and collaboration with other institutions (IMDEA).

It is a multidisciplinary group dedicated mainly to healthcare activities that works in close collaboration with the biobank. Research activities are embedded in the daily clinical activity.

Main publications in pancreatic cancer:

  1. Cámara JC, Martin-Valadés JI, López-Alfonso A, et al. Clinical outcomes of FOLFIRINOX and gemcitabine - nab paclitaxel for metastatic pancreatic cancer in the real world setting Fernando Franco. Clin Transl Oncol. 2021; 23(4): 812-19.
  2. Ruiz-Casado A, Franco F, Manso M, et al. Some unanswered questions about elderly patients with metastatic pancreatic cancer. J Geriatr Oncol. 2020; 11(6): 1032-33. 
  3. Ruiz-Casado A, Gutiérrez D, Juez I. Erysipeloid rash: a rare adverse event induced by gemcitabine. J Cancer Res Ther. 2015; 11(4): 1024. 
Ana Ruíz Casado

Principal Investigator

Group members

  • Ana Ruiz Casado
  • Antonio Sánchez Ruiz
  • Lourdes Gutiérrez Sanz
  • Mariano González-Haba Ruiz
  • Belén Agudo Castillo
  • Daniel de la Iglesia
  • Manuel Jiménez Garrido
  • Jose Luis Lucena
  • Alberto Pueyo
  • Matías Cea
  • Antonio Sánchez

Other groups